<DOC>
	<DOCNO>NCT00001999</DOCNO>
	<brief_summary>To evaluate whether immune globulin ganciclovir ( DHPG ) result faster initial response compare DHPG alone . To evaluate whether immune globulin DHPG give long duration remission DHPG alone ( i.e . 16 week ) . To evaluate toxicity combination DHPG immune globulin compare DHPG alone . To evaluate difference two group regard survival , immune function , CMV viremia viruria .</brief_summary>
	<brief_title>A Pilot Study Obtain Preliminary Information Regarding Efficacy Safety Combination Immune Globulin Ganciclovir Compared Ganciclovir Alone Treatment Sight-Threatening CMV Retinitis Patients With AIDS</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<criteria>Inclusion Criteria Patients must follow : First episode sightthreatening CMV retinitis . At least one pending culture CMV blood urine prior entry . Life expectancy &gt; 6 month . Karnofsky performance = &gt; 60 . Ability understand nature study , comply study requirement , sign inform consent . Exclusion Criteria Coexisting Condition : Patients follow condition exclude : Known selective IGA deficiency antibody IgA . History previous episode sightthreatening CMV retinitis . Patients follow exclude : Previous episode sightthreatening CMV retinitis . Concomitant treatment investigational agent except ddI ddC . Life expectancy &lt; 6 month . Continued alcohol drug abuse . Known selective IgA deficiency know antibody IgA . Karnofsky performance &lt; 60 . Other investigational agent except ddI ddC . ddI ddC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1993</verification_date>
	<keyword>Retinitis</keyword>
	<keyword>Gamma-Globulins</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Immunization , Passive</keyword>
</DOC>